Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (JDMF) for Betahistine Dimesilate Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Betahistine Dimesilate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 IWAKI SEIYAKU
    Japan
    		 SperaNexus Inc. 217MF10043 Betahistine mesilate 2005-05-20 2008-06-10 4-8-2 Nihonbashi Honcho, Chuo-ku, Tokyo
    26/09/2024 Kanto Chemical
    Japan
    		 Kanto Chemical Co., Ltd. 221MF10123 Betahistine mesilate 2009-06-23 2016-02-29 3-2-8 Nihonbashi Honcho, Chuo-ku, Tokyo